Percentage of Women Mohs Fellows, Program Directors Has Increased
FRIDAY, Aug. 18, 2023 (HealthDay News) — Since 1996, there has been an increase in the percentage of women in Mohs micrographic surgery (MMS) fellowships and program directors (PDs), according to a research letter published online Aug. 9 in JAMA Derm…
Learn MoreWHO Monitoring Highly Mutated New Strain of COVID-19, Now Spotted in Michigan
FRIDAY, Aug. 18, 2023 (HealthDay News) — A new COVID-19 variant with very few known cases but many mutations has been swiftly moved into the World Health Organization “variant under monitoring” classification.So far, four known cases of the variant, …
Learn MoreBlinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy
FRIDAY, Aug. 18, 2023 (HealthDay News) — Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemicals into his eyes.“If I had been standing a foot left or right, it wouldn’t have hit me …
Learn MoreWhat Is Chamomile Good For? Benefits, Side Effects & Drug Interactions
Chamomile is a familiar herb and when brewed in tea, it’s a popular element in alternative and holistic medicine.Where does it come from, what health benefits does it offer and most important, is it safe? Dr. Chiti Parikh, a New York City specialist i…
Learn MoreQuizá sea seguro que algunas pacientes con un cáncer de mama inicial prescindan de la radiación
JUEVES, 17 de agosto de 2023 (HealthDay News) — Muchas mujeres con un cáncer de mama temprano se someten a una cirugía para conservar el seno junto con radiación para acabar con cualquier célula cancerosa errante, pero quizá sea seguro que algunas pr…
Learn More¿Podría el Ativan ser peligroso para las personas con un cáncer de páncreas?
JUEVES, 17 de agosto de 2023 (HealthDay News) — A veces, a las personas con un cáncer de páncreas les recetan lorazepam (Ativan), una benzodiacepina, para la ansiedad, pero podría estar dañando su salud. Un nuevo estudio encontró que este tratamiento…
Learn MoreUna corte de apelaciones ratifica las restricciones de la pastilla para abortar
JUEVES, 17 de agosto de 2023 (HealthDay News) — La mifepristona, la pastilla para abortar, debería seguir siendo legal en Estados Unidos, pero con unas restricciones significativas para su acceso, dictaminó el miércoles una corte federal de apelacion…
Learn More